Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Christine Seymour"'
Publikováno v:
Genetics in Medicine Open, Vol 1, Iss 1, Pp 100237- (2023)
Externí odkaz:
https://doaj.org/article/4eb503d62011407e96b83f0bc21c5f13
Autor:
Alyssa Rippert, Sarah Trackman, Danielle Burstein, J. William Gaynor, Heather Griffis, Christine Seymour, Rebecca Ahrens-Nicklas
Publikováno v:
Genetics in Medicine Open, Vol 1, Iss 1, Pp 100307- (2023)
Externí odkaz:
https://doaj.org/article/5d5667c682eb401b93fedccbffbd24a8
Autor:
Lenton, Simon1 (AUTHOR)
Publikováno v:
Child: Care, Health & Development. May2004, Vol. 30 Issue 3, p255-256. 2p.
Autor:
Simon Lenton
Publikováno v:
Child: Care, Health and Development. 30:255-256
Autor:
Gary A. Heiman, Jessica Rispoli, Christine Seymour, James F. Leckman, Robert A. King, Thomas V. Fernandez
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Tourette disorder (TD) and other chronic tic disorders are neurodevelopmental/neuropsychiatric disorders characterized by motor and/or vocal tics. Family studies indicate that TD strongly aggregates within families and that other chronic
Externí odkaz:
https://doaj.org/article/635205f6c1384757a1fef77c028314b9
Publikováno v:
Journal of genetic counselingREFERENCES. 30(6)
Lack of consistent insurance coverage for genetic counseling services billed under Current Procedural Terminology (CPT) code 96040 creates a barrier for access to this service. This retrospective study examined coverage and reimbursement for reproduc
Covers a widespread view of Quality by Design (QbD) encompassing the many stages involved in the development of a new drug product. The book provides a broad view of Quality by Design (QbD) and shows how QbD concepts and analysis facilitate the devel
Publikováno v:
Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7245d8b68eda75639d0fbcd32fd0624
https://doi.org/10.1002/9781119356189
https://doi.org/10.1002/9781119356189
Publikováno v:
European Journal of Endocrinology. 154:119-124
Objective: Depot GnRH agonists are commonly used in the treatment of central precocious puberty (CPP). The triptorelin 11.25 mg 3-month depot, currently used in adult indications, had not previously been evaluated in CPP. Design: This was a multicent